Showing results (191-200 of 238) with videos related to
Sort By:
Pageof 24
The Journal of Pathology. Clinical Research|March 27, 2023
The effectiveness of neoadjuvant chemoradiotherapy in oesophageal adenocarcinoma with presence of extracellular mucin, signet-ring cells, and/or poorly cohesive cellsMaria J Valkema, Anne-Marie Vos, Rachel S van der Post, et al.Radiology|August 25, 2005
Esophageal cancer: CT, endoscopic US, and FDG PET for assessment of response to neoadjuvant therapy--systematic reviewMarinke Westerterp, Henderik L van Westreenen, Johannes B Reitsma, et al.Oncotarget|December 22, 2017
Pattern of p53 protein expression is predictive for survival in chemoradiotherapy-naive esophageal adenocarcinomaFiebo J C Ten Kate, Lucia Suzuki, Lambert C J Dorssers, et al.Endoscopy|March 2, 2021
Predictive value of endoscopic esophageal findings for residual esophageal cancer after neoadjuvant chemoradiotherapyRuben D van der Bogt, Berend J van der Wilk, Suzan Nikkessen, et al.Journal of Surgical Oncology|September 28, 2010
Lymphatic micrometastases in patients with early esophageal adenocarcinomaBrechtje A Grotenhuis, Mark van Heijl, Bas P L Wijnhoven, et al.Digestive Surgery|April 4, 2009
Diagnostic strategies for pre-treatment staging of patients with oesophageal cancerMark van Heijl, Jikke M T Omloo, Mark I van Berge Henegouwen, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 5, 2020
Surveillance of Clinically Complete Responders Using Serial 18F-FDG PET/CT Scans in Patients with Esophageal Cancer After Neoadjuvant ChemoradiotherapyMaria J Valkema, Berend J van der Wilk, Ben M Eyck, et al.The British Journal of Surgery|February 12, 2025
Detecting residual disease after neoadjuvant chemoradiotherapy for oesophageal squamous cell carcinoma: The prospective multicentre preSINO trialYang Yang, Zhichao Liu, Ian Wong, et al.JMIR Research Protocols|June 30, 2015
Accuracy of Detecting Residual Disease After Cross Neoadjuvant Chemoradiotherapy for Esophageal Cancer (preSANO Trial): Rationale and ProtocolBo Jan Noordman, Joel Shapiro, Manon Cw Spaander, et al.Annals of Surgery|March 29, 2017
Impact of Surgical Approach on Long-term Survival in Esophageal Adenocarcinoma Patients With or Without Neoadjuvant ChemoradiotherapyBo Jan Noordman, David van Klaveren, Mark I van Berge Henegouwen, et al.Pageof 24